Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations.
第一作者:
Ivan S,Moiseev
第一单位:
R.M. Gorbacheva Memorial Institute of Hematology, Oncology and Transplantation, Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russian Federation.
作者:
主题词
青少年(Adolescent);成年人(Adult);环磷酰胺(Cyclophosphamide);女(雌)性(Female);移植物存活(Graft Survival);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);免疫抑制剂(Immunosuppressive Agents);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);手术后医护(Postoperative Care);术前用药法(Premedication);组织供者(Tissue Donors);移植预处理(Transplantation Conditioning);移植, 同种(Transplantation, Homologous);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.1111/ejh.13030
PMID
29360184
发布时间
2018-09-18
- 浏览7
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文